These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8632719)

  • 1. Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: possible implications for the treatment of psychiatric disorders.
    Debonnel G; de Montigny C
    Life Sci; 1996; 58(9):721-34. PubMed ID: 8632719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems.
    Gronier B; Debonnel G
    Eur J Pharmacol; 1999 Mar; 368(2-3):183-96. PubMed ID: 10193654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current hypotheses on sigma receptors and their physiological role: possible implications in psychiatry.
    Debonnel G
    J Psychiatry Neurosci; 1993 Jul; 18(4):157-72. PubMed ID: 8373754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physiological function of sigma receptors: central pharmacological effects of sigma ligands].
    Nabeshima T; Okuyama S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Apr; 14(2):51-76. PubMed ID: 8042346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders.
    Hayashi T; Su TP
    CNS Drugs; 2004; 18(5):269-84. PubMed ID: 15089113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct neuroprotective profiles for sigma ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies.
    Lockhart BP; Soulard P; Benicourt C; Privat A; Junien JL
    Brain Res; 1995 Mar; 675(1-2):110-20. PubMed ID: 7796119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modulation of neuronal activities in the central nervous system via sigma receptors].
    Ishihara K; Sasa M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Feb; 22(1):23-30. PubMed ID: 11917506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral pharmacology of sigma-ligands.
    Skuza G; Wedzony K
    Pharmacopsychiatry; 2004 Nov; 37 Suppl 3():S183-8. PubMed ID: 15547784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sigma binding sites in the brain; an emerging concept for multiple sites and their relevance for psychiatric disorders.
    Itzhak Y; Stein I
    Life Sci; 1990; 47(13):1073-81. PubMed ID: 2172677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of sigma and PCP receptors after chronic administration of haloperidol and phencyclidine in mice.
    Itzhak Y; Alerhand S
    FASEB J; 1989 May; 3(7):1868-72. PubMed ID: 2541039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of [3H] dopamine release from mesolimbic and mesocortical areas of guinea pig brain by sigma receptors.
    Weatherspoon JK; Gonzalez-Alvear GM; Frank AR; Werling LL
    Schizophr Res; 1996 Jul; 21(1):51-62. PubMed ID: 8998276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. sigma receptor ligands attenuate N-methyl-D-aspartate cytotoxicity in dopaminergic neurons of mesencephalic slice cultures.
    Shimazu S; Katsuki H; Takenaka C; Tomita M; Kume T; Kaneko S; Akaike A
    Eur J Pharmacol; 2000 Jan; 388(2):139-46. PubMed ID: 10666505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation by sigma ligands of intracellular free Ca++ mobilization by N-methyl-D-aspartate in primary culture of rat frontal cortical neurons.
    Hayashi T; Kagaya A; Takebayashi M; Shimizu M; Uchitomi Y; Motohashi N; Yamawaki S
    J Pharmacol Exp Ther; 1995 Oct; 275(1):207-14. PubMed ID: 7562551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct modulatory roles of sigma receptor subtypes on glutamatergic responses in the dorsal hippocampus.
    Bermack JE; Debonnel G
    Synapse; 2005 Jan; 55(1):37-44. PubMed ID: 15499608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs.
    Snell LD; Johnson KM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):938-46. PubMed ID: 2875174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of [3H]dopamine release from rat striatal slices by sigma receptor ligands.
    Gonzalez-Alvear GM; Werling LL
    J Pharmacol Exp Ther; 1994 Oct; 271(1):212-9. PubMed ID: 7965717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by sigma receptor ligand, MS-377, of N-methyl- D-aspartate-induced currents in dopamine neurons of the rat ventral tegmental area.
    Yamazaki Y; Ishioka M; Matsubayashi H; Amano T; Sasa M
    Psychopharmacology (Berl); 2002 Apr; 161(1):64-9. PubMed ID: 11967632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sigma and phencyclidine receptors in the brain-endocrine-immune axis.
    Wolfe SA; De Souza EB
    NIDA Res Monogr; 1993; 133():95-123. PubMed ID: 8232518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
    Monnet FP; de Costa BR; Bowen WD
    Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MS-377, a selective sigma receptor ligand, indirectly blocks the action of PCP in the N-methyl-D-aspartate receptor ion-channel complex in primary cultured rat neuronal cells.
    Karasawa J; Yamamoto H; Yamamoto T; Sagi N; Horikomi K; Sora I
    Life Sci; 2002 Feb; 70(14):1631-42. PubMed ID: 11991251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.